Home
Corona Remedies Ltd Share Price History
NSE : 15 Dec, 2025
1438.4376.4 (35.4%)
Prev Close
1062.0
Open Price
1470.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
0
Today's High / Low
1497.8 / 1413.0
52 WK High / Low
1497.8 / 1413.0
Market Price of Corona Remedies Ltd
1M
1Y
3Y
5Y
Monitoring Corona Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 13.89 |
| YoY Gr. | - |
| Net Profit (Cr.) | 85 |
| BVPS | 66.8 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 24.94 |
| Op. Profit Mgn % | 15.3 |
| Net Profit Mgn % | 9.61 |
| Debt to Equity % | 0.07 |
Latest Shareholding
Promoters Holdings Over Time
About Corona Remedies Ltd
- Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
- Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
- A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
- The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Corona Remedies Ltd's share price history?
Key events that impact Corona Remedies Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Corona Remedies Ltd's share price history?
Stock splits reduce the nominal price of Corona Remedies Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Corona Remedies Ltd?
Dividends can influence Corona Remedies Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Corona Remedies Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Corona Remedies Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Corona Remedies Ltd’s share price history?
To understand Corona Remedies Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
